S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

AGLE Aeglea BioTherapeutics Inc

12.01

0.00 (0.00%)

Last Updated: 10:00:00

Delayed by 15 minutes

Form POS AM - Post-Effective amendments for registration statement

Article too big to display. Click here to view on the SEC website

Aeglea BioTherapeutics (NASDAQ:AGLE)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Aeglea BioTherapeutics Charts.

Aeglea BioTherapeutics (NASDAQ:AGLE)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Aeglea BioTherapeutics Charts.

Aeglea BioTherapeutics Inc News

Form EFFECT - Notice of Effectiveness
Tuesday 30 April 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 26 April 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Friday 26 April 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 26 April 2024 (2 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Tuesday 2 April 2024 (3 months ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Wednesday 20 March 2024 (3 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 19 March 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 18 March 2024 (3 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Friday 15 March 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 November 2023 (7 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 28 November 2023 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 28 November 2023 (7 months ago) • Edgar (US Regulatory)

More Aeglea BioTherapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions